Junel Tablet
Product Images NDC 82804-172

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Junel (NDC 82804-172). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82804-172-21 (Image 01)

Label for Junel 1mg/20mcg 21 Day Tablets, an oral tablet drug. It is labeled RX Only and distributed by Proficient Rx LP, Thousand Oaks, CA. The label notes a product ID and manufacturer as Teva Pharmaceuticals USA, Inc., North Wales, PA. Instructions include storing at 20°-25°C and keeping medication out of reach of children. The label includes multiple small duplicate labels and barcodes.*

FDA Label Image

Norethindrone Acetate, Usp Structural Formula (Image 1)

Chemical structure of Norethindrone Acetate, the active ingredient in Junel 21 Day oral tablets. The diagram shows the molecule's steroid backbone with attached functional groups as part of its pharmacologically active form.*

FDA Label Image

Junel 1.5/30 Blister Image (Image 10)

An instructional diagram showing directions for taking Junel 21 Day oral tablets. It illustrates a three-week pill pack arranged by days of the week (Sunday to Saturday) and weeks 1 to 3, with arrows indicating to start on Sunday or day 1 according to menstruation and to take pills from left to right each week. The image helps guide the timing and order for daily tablet intake.*

FDA Label Image

Junel Fe 1/20 Blister Image (Image 11)

An instructional diagram showing a 28-day pill pack for Junel Fe containing norethindrone acetate and ethinyl estradiol tablets along with ferrous fumarate tablets. The diagram provides guidance for both Sunday and Day 1 starters on how to begin taking the pills and the direction to take the tablets from left to right each week, labeled from Week 1 to Week 4 with days of the week marked at the top.*

FDA Label Image

Junel Fe 1.5/30 Blister Image (Image 12)

An instructional diagram showing the weekly pill layout for Junel 21 Day oral tablets. It includes directions for starting the pack on Sunday or the first day of menstruation, with an arrow indicating to take pills from left to right across each week. The blister pack displays four weekly rows labeled Week 1 to Week 4, with individual daily pills under Sunday through Saturday columns, totaling 28 days of tablets.*

FDA Label Image

Ethinyl Estradiol, Usp Structural Formula (Image 2)

Chemical structure diagram of Ethinyl Estradiol, an active ingredient in Junel 21 Day (Norethindrone Acetate and Ethinyl Estradiol) oral tablets by Proficient Rx LP.*

FDA Label Image

Table Ii (Image 3)

A bar chart depicting mortality rates (number of deaths per 100,000 women users) by age group (15-24, 25-34, 35-44, 45+). It compares four groups: ever-users (non-smokers), ever-users (smokers), controls (non-smokers), and controls (smokers). Mortality rates increase with age, with ever-users who smoke showing the highest rates, especially in the 45+ age group.*

FDA Label Image

Image 1 (Image 4)

A forest plot chart comparing 'Ever COC vs. Never COC Use' and 'Current COC use vs. Never-Use' across multiple studies. The horizontal axis represents effect estimates ranging approximately from -1.5 to 2. Effect estimates with their confidence intervals are shown as horizontal lines with markers for individual studies. Numeric values for odds ratios (OR), hazard ratios (HR), and relative risks (RR) are listed on the right side.*

FDA Label Image

Image 1 (Image 5)

An instructional diagram for Junel 21 Day tablets showing a 3-week blister pack with rows labeled Week 1, Week 2, and Week 3. It provides directions for starting on Sunday or Day-1 of the menstrual cycle, indicating to place the corresponding day label strip at the top. Arrows show the pill-taking sequence from left to right each week.*

FDA Label Image

Image 2 (Image 6)

An instructional diagram showing a 21-day blister pack for Junel 21 Day tablets (norethindrone acetate and ethinyl estradiol). The pack features a day label strip for Sunday or Day-1 starters, with the cycle organized into three weeks of tablets. Arrows indicate pill-taking direction from left to right each week.*

FDA Label Image

Image 3 (Image 7)

Blister pack of Junel 21 Day oral tablets containing norethindrone acetate and ethinyl estradiol. The pack is organized in four rows labeled Week 1 through Week 4, with days of the week labeled horizontally from Sunday to Saturday. Instructions indicate to start at the left and take pills from left to right each week, with guidance for DAY-1 and SUNDAY starters. The label also includes storage instructions (20° to 25°C) and the pack count is 28 days.*

FDA Label Image

Image 4 (Image 8)

An instructional diagram for Junel 21 Day tablets showing a 28-day pill pack layout with four weeks labeled vertically and days of the week labeled horizontally across the top. The diagram indicates starting points for Sunday and Day-1 starters and directs users to take pills from left to right each week. Storage instructions are noted at the top of the pack.*

FDA Label Image

Junel 1/20 Blister Image (Image 9)

An instructional diagram for Junel 21 Day oral tablets showing a 21-pill blister pack arranged in three rows labeled Week 1 to Week 3 and seven columns labeled Sunday through Saturday. Arrows indicate to take the pills from left to right each week. Text explains instructions for Sunday starters and Day-1 starters to align the day label with the first day of the period.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.